Multiple Sclerosis: Neuroimmunologic Puzzle

Overview

Journal Clin Lab Med

Specialty Pathology

Date 1986 Mar 1

PMID 3514094

Citations 1

Authors

B P Barna

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS), a chronic disease with a relapsing and remitting course, is the most common neuroimmunologic condition in the United States. The hallmarks of the disease are focal demyelination and inflammation within the central nervous system (CNS). Because histopathologic changes can be identified only at autopsy, attention has been directed at formulating standardized clinical and laboratory procedures to aid in MS diagnosis. Currently, there are no MS-specific clinical or laboratory tests, but detection of abnormality in cerebrospinal fluid (CSF) IgG is important in supporting clinical evidence of disease. A number of other immunologic abnormalities have been recognized in MS, including the presence of T- and B-lymphocytes within the CNS and alterations in circulating suppressor T-lymphocytes. These findings have been interpreted as indicating disturbed immunoregulation associated with a chronic autoimmune response within the CNS. Evidence implicates viral infection in the pathogenesis of MS but the cause of the disease remains unknown.

Citing Articles

Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.

Schwartz M, Butovsky O, Kipnis J J Neuroimmune Pharmacol. 2007; 1(1):4-10.

PMID: 18040786 DOI: 10.1007/s11481-005-9010-2.

References

Link H, TIBBLING G . Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest. 1977; 37(5):397-401. DOI: 10.1080/00365517709091498. View

Ebers G . A study of CSF idiotypes in multiple sclerosis. Scand J Immunol. 1982; 16(2):151-61. DOI: 10.1111/j.1365-3083.1982.tb00708.x. View

Tourtellotte W, POTVIN A, Fleming J, Murthy K, Levy J, Syndulko K . Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology. 1980; 30(3):240-4. DOI: 10.1212/wnl.30.3.240. View

Davison A, Cuzner M . Immunochemistry and biochemistry of myelin. Br Med Bull. 1977; 33(1):60-6. DOI: 10.1093/oxfordjournals.bmb.a071398. View

Chu A, Sever J, Madden D, Iivanainen M, Leon M, Wallen W . Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann Neurol. 1983; 13(4):434-9. DOI: 10.1002/ana.410130410. View

Miller J, Burke A, Bever C . Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases. Ann Neurol. 1983; 13(1):53-8. DOI: 10.1002/ana.410130112. View

TIBBLING G, Link H, OHMAN S . Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977; 37(5):385-90. DOI: 10.1080/00365517709091496. View

Bach M, Martin C, Cesaro P, Eizenbaum J, Degos J . T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases. J Neuroimmunol. 1985; 7(5-6):331-43. View

Johnson K . Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis. Neurology. 1980; 30(7 Pt 2):106-9. DOI: 10.1212/wnl.30.7_part_2.106. View

10.

Hershey L, Trotter J . The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation. Ann Neurol. 1980; 8(4):426-34. DOI: 10.1002/ana.410080415. View

11.

Laterre E, CALLEWAERT A, Heremans J, Sfaello Z . Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology. 1970; 20(10):982-90. DOI: 10.1212/wnl.20.10.982. View

12.

Tourtellotte W, Staugaitis S, Walsh M, Shapshak P, Baumhefner R, POTVIN A . The basis of intra-blood-brain-barrier IgG synthesis. Ann Neurol. 1985; 17(1):21-7. DOI: 10.1002/ana.410170107. View

13.

Ebers G, Paty D . CSF electrophoresis in one thousand patients. Can J Neurol Sci. 1980; 7(4):275-80. DOI: 10.1017/s0317167100022733. View

14.

Sindic C, Cambiaso C, Masson P, Laterre E . The binding of myelin basic protein to the Fc region of aggregated IgG and to immune complexes. Clin Exp Immunol. 1980; 41(1):1-7. PMC: 1536910. View

15.

Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3):227-31. DOI: 10.1002/ana.410130302. View

16.

Paty D, Kastrukoff L . Suppressor T cells in MS: do changes in numbers vary with clinical activity?. Ann N Y Acad Sci. 1984; 436:266-70. DOI: 10.1111/j.1749-6632.1984.tb14798.x. View

17.

Narayan O, Penney Jr J, Johnson R, Herndon R, Weiner L . Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med. 1973; 289(24):1278-82. DOI: 10.1056/NEJM197312132892405. View

18.

Antel J, Arnason B, Medof M . Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol. 1979; 5(4):338-42. DOI: 10.1002/ana.410050406. View

19.

Panitch H, Francis G . T-lymphocyte subsets in cerebrospinal fluid in multiple sclerosis. N Engl J Med. 1982; 307(9):560-1. DOI: 10.1056/nejm198208263070921. View

20.

Mandler R, Goren H, Valenzuela R . Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis. Neurology. 1982; 32(3):296-8. DOI: 10.1212/wnl.32.3.296. View